TARAH WILSON: Open Payments
NPI 1548735228 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 37 payments from 10 companies in 2025. Trend: 2023 $963 · 2024 $1,858 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $201 |
| HEARTFLOW, INC. | 1 | $154 |
| AstraZeneca Pharmaceuticals LP | 7 | $153 |
| Amgen Inc. | 3 | $56 |
| PFIZER INC. | 3 | $52 |
| Merck Sharp & Dohme LLC | 3 | $45 |
| Novo Nordisk Inc | 2 | $45 |
| Impulse Dynamics (USA) Inc. | 1 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: LEQVIO, FFRct, FARXIGA, REPATHA, ELIQUIS, VERQUVO, Wegovy, Optimizer.
Industry payments across TX — which companies pay providers there.
